Search

Search Constraints

You searched for: Author/Creator Karlsson, Cecilia

Search Results

3. A PET study comparing receptor occupancy by five selective cannabinoid 1 receptor antagonists in non-human primates. (February 2016)

4. A PET study comparing receptor occupancy by five selective cannabinoid 1 receptor antagonists in non-human primates. (February 2016)

5. Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials. (29th November 2021)

6. Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials. Issue 1 (January 2022)

8. Effects of 6 weeks of treatment with dapagliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, on myocardial function and metabolism in patients with type 2 diabetes: A randomized, placebo‐controlled, exploratory study. Issue 7 (12th March 2021)

9. Effects of DAPAgliflozin on CARDiac substrate uptake, myocardial efficiency, and myocardial contractile work in type 2 diabetes patients—a description of the DAPACARD study. (2nd January 2019)

10. Effects of dapagliflozin on volume status and systemic haemodynamics in patients with chronic kidney disease without diabetes: Results from DAPASALT and DIAMOND. Issue 8 (1st June 2022)